Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis
Authors
Keywords
21-gene recurrence score assay, Oncotype DX, Breast cancer, Clinical practice
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 157, Issue 3, Pages 427-435
Publisher
Springer Nature
Online
2016-05-20
DOI
10.1007/s10549-016-3833-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Invasive Breast Cancer
- (2017) Robert W. Carlson et al. Journal of the National Comprehensive Cancer Network
- Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer
- (2016) Megan C. Roberts et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Lyndsay N. Harris et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario
- (2016) Mark N. Levine et al. JOURNAL OF CLINICAL ONCOLOGY
- Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age
- (2015) Sandra M. Swain et al. ADVANCES IN THERAPY
- Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland
- (2015) Lillian Smyth et al. BREAST CANCER RESEARCH AND TREATMENT
- Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapy
- (2015) Lindsey Enewold et al. BREAST CANCER RESEARCH AND TREATMENT
- Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing
- (2015) Megan C. Roberts et al. BREAST CANCER RESEARCH AND TREATMENT
- Decision-making impact on adjuvant chemotherapy allocation in early node-negative breast cancer with a 21-gene assay: systematic review and meta-analysis
- (2015) Federico Augustovski et al. BREAST CANCER RESEARCH AND TREATMENT
- Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
- (2015) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term cost–effectiveness of Oncotype DX®versus current clinical practice from a Dutch cost perspective
- (2015) Michelle Kip et al. Journal of Comparative Effectiveness Research
- Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009
- (2015) Michaela A. Dinan et al. JAMA Oncology
- Economic Impact of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in France
- (2015) Gregory Katz et al. PLoS One
- The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis
- (2013) Josh J. Carlson et al. BREAST CANCER RESEARCH AND TREATMENT
- Adoption of Gene Expression Profile Testing and Association With Use of Chemotherapy Among Women With Breast Cancer
- (2012) Michael J. Hassett et al. JOURNAL OF CLINICAL ONCOLOGY
- 21-Gene recurrence scores
- (2011) Mary Jo Lund et al. CANCER
- Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals
- (2010) P. Barthélémy et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
- (2009) Kathy S Albain et al. LANCET ONCOLOGY
- Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features
- (2008) Lori J. Goldstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Development of the 21-Gene Assay and Its Application in Clinical Practice and Clinical Trials
- (2008) Joseph A. Sparano et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now